Exhibit 32.1

                            CERTIFICATION PURSUANT TO

                             18 U.S.C. SECTION 1350,

                             AS ADOPTED PURSUANT BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly  Report of Evolve Oncology Inc., on Form 10-QSB
for the period ending August 31, 2004 as filed with the  Securities and Exchange
Commission on the date hereof (the "Report"),  the undersigned,  Nigel Rulewski,
Chief Executive Officer and Principal Executive Officer of the Company, certify,
pursuant to 18 U.S.C. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley
Act of 2002, that:

(1)   The Report fully  complies with the  requirements  of section 13 (a) or 15
      (d) of the Securities Exchange Act of 1934; and

(2)   The information  contained in the Report fairly presents,  in all material
      respects, the financial condition and result of operations of the Company.


                         Date: February 1, 2006

                         By: /s/ Nigel Rulewski
                         -----------------------------
                         Nigel Rulewski
                         CEO
                         (Principal Executive Officer)


A signed  original of this written  statement  required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the  electronic  version of this written  statement
has been  provided  to the  Company  and will be  retained  by the  Company  and
furnished to the Securities and Exchange Commission or its staff upon request.